FARMACEUTICA PARAGUAYA S.A. secures contract for CVE 01/2022 - Acquisition of Paclitaxel 100 mg, Atezolizumab 1200 mg, Palbociclib 125mg, 10mg Lenvatinib and 4 mg -Judicial Judicial

Paraguay, Aug. 21 -- Paraguay based FARMACEUTICA PARAGUAYA S.A. has secured contract from Ministerio de Salud Publica y Bienestar Social / Poder Ejecutivo for CVE 01/2022 - Acquisition of Paclitaxel 100 mg, Atezolizumab 1200 mg, Palbociclib 125mg, 10mg Lenvatinib and 4 mg -Judicial Judicial. The value of the contract is worth 234000000 PYG.

Published by HT Digital Content Services with permission from Pivotal Sources....